# Xadago

NDC: 27505-110
Generic name: safinamide mesylate
Labeler / Manufacturer: MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20170508

FDA application: NDA207145

## Active ingredients

- SAFINAMIDE MESYLATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27505-110"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27505-110
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4d65f28-983f-42b4-bb23-023ae0fe81b2